BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32128678)

  • 1. Establishment of a Genomic-Clinicopathologic Nomogram for Predicting Early Recurrence of Hepatocellular Carcinoma After R0 Resection.
    Yu B; Liang H; Ye Q; Wang Y
    J Gastrointest Surg; 2021 Jan; 25(1):112-124. PubMed ID: 32128678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma.
    Zhang Q; Ning G; Jiang H; Huang Y; Piao J; Chen Z; Tan X; Zhang J; Liu G
    Dis Markers; 2020; 2020():9180732. PubMed ID: 33520012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
    Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
    Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma.
    Wang Z; Pan L; Guo D; Luo X; Tang J; Yang W; Zhang Y; Luo A; Gu Y; Pan Y
    Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection: A large-scale, multicenter study.
    Zhang XP; Chen ZH; Zhou TF; Li LQ; Chen MS; Wen TF; Shi J; Guo WX; Wu MC; Lau WY; Cheng SQ;
    Eur J Surg Oncol; 2019 Sep; 45(9):1644-1651. PubMed ID: 30982657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel genomic-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma.
    Ni FB; Lin Z; Fan XH; Shi KQ; Ao JY; Wang XD; Chen RC
    Clin Chim Acta; 2020 May; 504():88-97. PubMed ID: 32032609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients.
    Wang Z; Zhang N; Lv J; Ma C; Gu J; Du Y; Qiu Y; Zhang Z; Li M; Jiang Y; Zhao J; Du H; Zhang Z; Lu W; Zhang Y
    Biomed Res Int; 2020; 2020():4037639. PubMed ID: 33163533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel molecular-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma.
    Zhang Z; Weng W; Huang W; Wu B; Zhou Y; Zhang J; Deng T; Ye W; Zhang J; Ao J; Zhang Q; Shi K
    Aging (Albany NY); 2020 Jun; 12(13):12896-12920. PubMed ID: 32611831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
    Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
    Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy.
    Feng LH; Sun HC; Zhu XD; Liu XF; Zhang SZ; Li XL; Li Y; Tang ZY
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):681-689. PubMed ID: 33189491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes].
    Rong HC; Zhao WF; Zheng N; Guo ZH; Wang YW; Huang XP
    Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):509-517. PubMed ID: 37365028
    [No Abstract]   [Full Text] [Related]  

  • 13. Preoperative and postoperative nomograms for predicting early recurrence of hepatocellular carcinoma without macrovascular invasion after curative resection.
    Zhang Y; Lei X; Xu L; Lv X; Xu M; Tang H
    BMC Surg; 2022 Jun; 22(1):233. PubMed ID: 35715787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC.
    Huang K; Lu Z; Li L; Peng G; Zhou W; Ye Q
    Hum Cell; 2021 Nov; 34(6):1830-1842. PubMed ID: 34487338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpressed PAQR4 predicts poor overall survival and construction of a prognostic nomogram based on PAQR family for hepatocellular carcinoma.
    Qu C; Ma T; Yan X; Li X; Li Y
    Math Biosci Eng; 2022 Jan; 19(3):3069-3090. PubMed ID: 35240821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy.
    Pan YX; Chen JC; Fang AP; Wang XH; Chen JB; Wang JC; He W; Fu YZ; Xu L; Chen MS; Zhang YJ; Li QJ; Zhou ZG
    Cancer Commun (Lond); 2019 Oct; 39(1):55. PubMed ID: 31601270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated nomogram combining lncRNAs classifier and clinicopathologic factors to predict the recurrence of head and neck squamous cell carcinoma.
    Cui J; Wen Q; Tan X; Piao J; Zhang Q; Wang Q; He L; Wang Y; Chen Z; Liu G
    Sci Rep; 2019 Nov; 9(1):17460. PubMed ID: 31767907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.